Growth and development of multicellular organisms are controlled by signaling systems that sense nutrition availability and metabolic status. We report a novel and surprising factor in Caenorhabditis elegans development, the monomethyl branched-chain fatty acid C17ISO, a product of leucine catabolism. We show here that C17ISO is an essential constituent in a novel mechanism that acts in parallel with the food-sensing DAF-2 (insulin receptor)/DAF-16 (FOXO) signaling pathway to promote post-embryonic development, and that the two pathways converge on a common target repressing cell cycle. We show that C17ISO homeostasis is regulated by a SREBP-1c-mediated feedback mechanism that is different from the SREBP-1c-mediated regulation of common fatty acid biosynthesis, as well as by peptide uptake and transport. Our data suggest that C17ISO may act as a chemical/nutritional factor in a mechanism that regulates post-embryonic development in response to the metabolic state of the organism. In Caenborhabditis elegans, environmental cues regulate the decision between two post-embryonic developmental options: reproductive growth and an adaptive larval arrest, known as diapause. There are two distinctive types of larval arrest, L1 (first larval stage) diapause and dauer formation (Johnson et al. 1984;Riddle and Alberts 1997;Muänoz 2003). Dauer larvae, third-stage larvae (dL3) with distinct structures and behaviors suited for long-term survival, are induced at the L1 larval stage by unfavorable growth conditions. The food-sensing insulin/DAF-2 receptor-stimulated pathway that negatively controls activity of a FOXO transcription factor, DAF-16, plays a critical role in dauer formation (Vowels and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.